170 related articles for article (PubMed ID: 27544389)
1. Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.
Stollberg S; Kämmerer D; Neubauer E; Schulz S; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Lupp A
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2239-47. PubMed ID: 27544389
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.
Deutsch AJ; Steinbauer E; Hofmann NA; Strunk D; Gerlza T; Beham-Schmid C; Schaider H; Neumeister P
Mod Pathol; 2013 Feb; 26(2):182-94. PubMed ID: 22936065
[TBL] [Abstract][Full Text] [Related]
4. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.
Deutsch AJ; Aigelsreiter A; Steinbauer E; Frühwirth M; Kerl H; Beham-Schmid C; Schaider H; Neumeister P
J Pathol; 2008 Aug; 215(4):431-44. PubMed ID: 18561120
[TBL] [Abstract][Full Text] [Related]
5. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.
Kaemmerer D; Träger T; Hoffmeister M; Sipos B; Hommann M; Sänger J; Schulz S; Lupp A
Oncotarget; 2015 Sep; 6(29):27566-79. PubMed ID: 26259237
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes.
Juntikka T; Vaittinen S; Vahlberg T; Jyrkkiö S; Minn H
Front Oncol; 2021; 11():710900. PubMed ID: 34307181
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
Kaemmerer D; Schindler R; Mußbach F; Dahmen U; Altendorf-Hofmann A; Dirsch O; Sänger J; Schulz S; Lupp A
BMC Cancer; 2017 Dec; 17(1):896. PubMed ID: 29282035
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
Kuo SH; Cheng AL
Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
[TBL] [Abstract][Full Text] [Related]
9. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue.
Dogan A; Du M; Koulis A; Briskin MJ; Isaacson PG
Am J Pathol; 1997 Nov; 151(5):1361-9. PubMed ID: 9358762
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.
Grünberger B; Wöhrer S; Streubel B; Formanek M; Petkov V; Puespoek A; Haefner M; Hejna M; Jaeger U; Chott A; Raderer M
J Clin Oncol; 2006 Mar; 24(9):1370-5. PubMed ID: 16549831
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
13. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
14. Gastric lymphomas: genetics and resistance to H. pylori eradication.
Isaacson PG; Du MQ
Verh Dtsch Ges Pathol; 2003; 87():116-22. PubMed ID: 16888902
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
[TBL] [Abstract][Full Text] [Related]
16. [Protein expression and clinical significance of cyclooxygenase 2 and nuclear factor kappa B in gastric mucosa-associated lymphoid tissue lymphoma].
Wu XL; Han SL; Wan L; Huang KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):163-6. PubMed ID: 18344086
[TBL] [Abstract][Full Text] [Related]
17. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.
Lange F; Kaemmerer D; Behnke-Mursch J; Brück W; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1227-1237. PubMed ID: 29696364
[TBL] [Abstract][Full Text] [Related]
18. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter pylori-independent gastric MALT lymphoma.
Kuo SH; Weng WH; Chen ZH; Hsu PN; Wu MS; Lin CW; Jeng HJ; Yeh KH; Tsai HJ; Chen LT; Cheng AL
Genes Chromosomes Cancer; 2011 Nov; 50(11):908-21. PubMed ID: 21837708
[TBL] [Abstract][Full Text] [Related]
20. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]